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Carotid artery aneurysm (CAA) is an extremely rare condition for
which open surgery has traditionally been considered the gold stan-
dard. Accordingly, the report by Zhou (one of the largest series
published) not only provides a timely update on contemporary prac-
tice but is also one of the first to propose that endovascularCAA repair
(ECAAR) may replace open surgery as the first line of treatment.
At first glance, the results of ECAAR do seem superior.
Notwithstanding the short follow-up period following ECAAR,
benefits include significant reductions in hospital stay (3 vs 9 days),
reduced 30-day death/stroke rates (4% vs 17%), a reduced rate of
cranial nerve injury (0% vs 17%), and a very low (0%) risk of stroke
and occlusion during follow-up. I was, however, struck by two
observations: First, are these results generalizable into clinical
practice (ie, should we all be changing to ECAAR now), and
second, are the authors really comparing “like with like” when
evaluating their experience of open repair and ECAAR?
With regard to generalizability, I suspect the answer is no. Few
can match this volume of experience, and it would be unwise for
everyone to change to ECAAR without at least considering that a
decision to refer this type of patient to a regional endovascular
center might be more appropriate. The obvious benefit of this type
of approach is that expertise, outcomes, and expensive human and
logistical resources can be optimized. This is not to belittle the role
of smaller units. Remember, even the Baylor Hospital took 20
years to recruit 63 CAA patients (an average of only 3 per year).
Second, several observations suggest that the two patient
groups are not strictly comparable. Although length of stay isimportant to health economists, it is of less relevance to patients,
who are more interested in facing the lowest risk of complications.
Zhou et al highlight the low early and late morbidity/mortality
associated with ECAAR. Closer scrutiny, however, shows that
three of the five cranial nerve injuries in the open surgery group
occurred in patients who had presented with infected post-CEA
pseudoaneurysms, a specific contraindication to ECAAR. If the
three post-CEA patients with infection are excluded from the open
group, the risk of cranial nerve injury falls from 17% to 7%,
Similarly, two of the three early strokes (open surgery group)
occurred in five patients undergoing open carotid ligation. As the
reader will recall, ligation was usually performed in patients in
whom distal control/access was not possible. According to the
Baylor group, ECAAR requires 2 cm of distal internal carotid
artery to land the stent, thus perhapsmaking this another subgroup
in which ECAA might not be possible. If the five open ligation
patients are excluded as not being strictly comparable, the stroke
rate following open surgery falls from 10% to 4%.
Notwithstanding the relatively short follow-up and an element
of case selection bias, the authors are to be congratulated for
having developed an important alternative to open surgery for
CAA. Having previously encountered profuse hemorrhage whilst
dissecting through a very friable and inflamed, symptomatic false
aneurysm following a carotid dissection, I would have welcomed
the opportunity to have considered (preoperatively) ECAAR as an
alternative management option.
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